n-benzyloxycarbonylprolylprolinal has been researched along with aromoline in 1 studies
| Studies (n-benzyloxycarbonylprolylprolinal) | Trials (n-benzyloxycarbonylprolylprolinal) | Recent Studies (post-2010) (n-benzyloxycarbonylprolylprolinal) | Studies (aromoline) | Trials (aromoline) | Recent Studies (post-2010) (aromoline) |
|---|---|---|---|---|---|
| 39 | 0 | 7 | 6 | 0 | 2 |
| Protein | Taxonomy | n-benzyloxycarbonylprolylprolinal (IC50) | aromoline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Cahlikova, L; Hostalkova, A; Hulcova, D; Jun, D; Korabecny, J; Kucera, T; Kunes, J; Marikova, J; Novakova, L; Opletal, L; Perez, DI; Siatka, T | 1 |
1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and aromoline
| Article | Year |
|---|---|
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Berberis; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Plant Exudates | 2019 |